Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temporal Profile of Dexmedetomidine-Induced Analgesia Via EEG
NCT06946277Phase 4Not yet recruiting
- Sponsor
- China International Neuroscience Institute
- Start
- Nov 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in hip osteoarthritis, sponsored by China International Neuroscience Institute. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT06946277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06946277.